Drug Combination Successfully Targets Cancer's “Death Star” Protein - Technology Networks

A drug combination targeting multiple mutant versions of KRAS, which researchers termed cancer’s "death star" protein, has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.

A drug combination targeting multiple mutant versions of cancers death star protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid … [+6643 chars]

full article...